Check Out What Whales Are Doing With TMDX

High-rolling investors have positioned themselves bullish on TransMedics Gr TMDX, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in TMDX often signals that someone has privileged information.

Today, Benzinga's options scanner spotted 8 options trades for TransMedics Gr. This is not a typical pattern.

The sentiment among these major traders is split, with 37% bullish and 25% bearish. Among all the options we identified, there was one put, amounting to $40,560, and 7 calls, totaling $300,798.

Expected Price Movements

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $180.0 for TransMedics Gr over the last 3 months.

Volume & Open Interest Development

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for TransMedics Gr's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across TransMedics Gr's significant trades, within a strike price range of $75.0 to $180.0, over the past month.

TransMedics Gr Option Volume And Open Interest Over Last 30 Days

Noteworthy Options Activity:

About TransMedics Gr

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

In light of the recent options history for TransMedics Gr, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Present Market Standing of TransMedics Gr

• With a volume of 1,072,966, the price of TMDX is up 0.88% at $129.12.
• RSI indicators hint that the underlying stock may be overbought.
• Next earnings are expected to be released in 87 days.

Professional Analyst Ratings for TransMedics Gr

5 market experts have recently issued ratings for this stock, with a consensus target price of $123.8.

• Maintaining their stance, an analyst from TD Cowen continues to hold a Buy rating for TransMedics Gr, targeting a price of $130.
• Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on TransMedics Gr with a target price of $125.
• An analyst from Canaccord Genuity persists with their Buy rating on TransMedics Gr, maintaining a target price of $117.
• Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for TransMedics Gr, targeting a price of $127.
• An analyst from Piper Sandler downgraded its action to Overweight with a price target of $120.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for TransMedics Gr, Benzinga Pro gives you real-time options trades alerts.